BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 7556810)

  • 81. [Plasma-erythrocyte viscosity and evaluation of several pro- and anti-aggregating factors in NIDDM patients in metabolic decompensation state].
    Cortinovis A; Crippa A; Crippa M; Bosoni T; Moratti R
    Minerva Cardioangiol; 1992 Sep; 40(9):317-22. PubMed ID: 1470397
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Role of plasma ascorbate in diabetic microangiopathy.
    Ali SM; Chakraborty SK
    Bangladesh Med Res Counc Bull; 1989 Dec; 15(2):47-59. PubMed ID: 2629696
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Association among low whole blood viscosity, haematocrit, haemoglobin and diabetic retinopathy in subjects with type 2 diabetes.
    Irace C; Scarinci F; Scorcia V; Bruzzichessi D; Fiorentino R; Randazzo G; Scorcia G; Gnasso A
    Br J Ophthalmol; 2011 Jan; 95(1):94-8. PubMed ID: 20530659
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects.
    Hadjadj S; Aubert R; Fumeron F; Pean F; Tichet J; Roussel R; Marre M; ;
    Diabetologia; 2005 Jun; 48(6):1088-92. PubMed ID: 15875155
    [TBL] [Abstract][Full Text] [Related]  

  • 85. [Longitudinal studies on the prognostic significance of plasma fibrinogen in diabetes mellitus].
    Schmechel H; Beiküfner P; Panzram G
    Z Gesamte Inn Med; 1984 Sep; 39(18):453-7. PubMed ID: 6506821
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [Behavior of fibrinogen in diabetic patients in comparison with objective vascular measurements in the ocular fundus].
    Syrbe G; Oswald B; Jorke D; Jütte A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):853-8. PubMed ID: 2419213
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Blood fluidity in essential hypertension, arterial occlusive disease and diabetic angiopathies].
    Sternitzky R; Hänsgen K; Podhaisky H
    Z Gesamte Inn Med; 1991 Nov; 46(16):610-4. PubMed ID: 1792802
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Differences between plasma viscosity and proteins of types 1 and 2 diabetic Africans in early phase of diabetes.
    Memeh CU
    Horm Metab Res; 1993 Jan; 25(1):21-3. PubMed ID: 8428705
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Diabetic hypertension--the importance of fibrinogen and blood viscosity.
    Feher MD; Rampling MW; Sever PS; Elkeles RS
    J Hum Hypertens; 1988 Aug; 2(2):117-22. PubMed ID: 3244146
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Diabetes mellitus and microcirculation. Significance of diabetic angiopathy for the prognosis and course of diabetes mellitus, possibilities and bases of angiologic therapy].
    Semler P; Werner U
    Fortschr Med; 1976 Mar; 94(7):354-7. PubMed ID: 964891
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Rheological properties of white blood cells are changed in diabetic patients with microvascular complications.
    Vermes I; Steinmetz ET; Zeyen LJ; van der Veen EA
    Diabetologia; 1987 Jun; 30(6):434-6. PubMed ID: 3678663
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Increased blood viscosity in diabetic proliferative retinopathy.
    Lowe GD; Ghafour IM; Belch JJ; Forbes CD; Foulds WS; MacCuish AC
    Diabetes Res; 1986 Feb; 3(2):67-70. PubMed ID: 3698481
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Low serum C4 concentrations and microangiopathy in type I and type II diabetes.
    Cooper ME; Duff R; Buchanan R; McPherson J; Jerums G
    Br Med J (Clin Res Ed); 1986 Mar; 292(6523):801. PubMed ID: 3082449
    [No Abstract]   [Full Text] [Related]  

  • 94. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Alpha 2 globulins in diabetes mellitus].
    Müller H; Kluthe R
    Med Klin; 1971 Apr; 66(14):522-6. PubMed ID: 4101572
    [No Abstract]   [Full Text] [Related]  

  • 96. PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.
    Breddin HK; Krzywanek HJ; Althoff P; Schöffling K; Uberla K
    Horm Metab Res Suppl; 1985; 15():63-8. PubMed ID: 2934312
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Serum glycoproteins and diabetes mellitus].
    Petrescu M; Ciobanu F; Popescu E
    Stud Cercet Med Interna; 1967; 8(4):307-12. PubMed ID: 6082050
    [No Abstract]   [Full Text] [Related]  

  • 98. [Status of the sympatho-adrenal system in patients with diabetes mellitus: dependence on the course of the disease and the presence of late complications].
    Chandrashekar-Reddi KM; Balabolkin MI; Stoilov LD
    Probl Endokrinol (Mosk); 1994; 40(6):13-4. PubMed ID: 7740027
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Platelet adhesiveness in diabetes mellitus with and without vascular complications.
    Ramani A; Kumar S; Tyagi N
    J Assoc Physicians India; 1986 Nov; 34(11):792-3. PubMed ID: 3558304
    [No Abstract]   [Full Text] [Related]  

  • 100. [The physiopathological basis for hemorrheological changes in diabetes].
    Neri Serneri GG; Galanti G; Paoli G
    Ric Clin Lab; 1983; 13 Suppl 3():149-57. PubMed ID: 6369493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.